Impulse control disorders in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Vilas, Dolores ^a   Pont Sunyer, Claustre ^a   Tolosa, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Binge eating; Compulsive behavior; Dopamine agonists; Hypersexuality; Impulse control disorders; Parkinson's disease; Pathological gambling

Indexed keywords

AMANTADINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; SEROTONIN 2A RECEPTOR; ZONISAMIDE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 3 RECEPTOR; MOOD STABILIZER; ROPINIROLE;

AGE DISTRIBUTION; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COMPULSION; COMPULSIVE SHOPPING; COUNSELING; DISEASE SEVERITY; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSKINESIA; EARLY DIAGNOSIS; EATING DISORDER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HYPERSEXUALITY; HYPOMANIA; IMPULSE CONTROL DISORDER; IMPULSIVENESS; LOW DRUG DOSE; MANIA; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PHAGOMANIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK FACTOR; SEX DIFFERENCE; SUBSTITUTION THERAPY; SUBTHALAMIC NUCLEUS; WITHDRAWAL SYNDROME; BINGE EATING DISORDER; COMPULSIVE BUYING; DAILY LIFE ACTIVITY; MESOLIMBIC DOPAMINERGIC SYSTEM; PATHOGENESIS; PATIENT COUNSELING; PSYCHOSOCIAL CARE; QUALITY OF LIFE;

EID: 84858666771     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70026-8     Document Type: Article

References (29)

1. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006;21:2068-72.
2. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-8.
3. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
4. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67:1254-7.
5. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-95.
6. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003;61:422-3.
7. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377-81.
8. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-96.
9. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005;11:381-6.
10. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009;24:1461-7.
11. American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Association; 2000.
12. Molina JA, Sainz-Artiga MJ, Fraile A, Jimenez-Jimenez FJ, Villanueva C, Orti-Pareja M, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 2000;15:869-72.
13. Djamshidian A, Averbeck BB, Lees AJ, O'Sullivan SS. Clinical aspects of impulsive compulsive behaviours in Parkinson's disease. J Neurol Sci 2011;310:183-8.
14. Kaplan HI SB, Grebb JA. Synopsis of Psychiatry, 7th edn. Baltimore: Williams & Wilkins; 1994.
15. Ferrara JM, Stacy M. Impulse-control disorders in Parkinson's disease. CNS Spectr 2008;13:690-8.
16. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524-9.
17. McElroy SL, Keck Jr PE, Pope Jr HG, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994;55:242-8.
18. Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011;69:986-96.
19. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010;33:81-7.
20. Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol 2011;24:324-30.
21. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132:1376-85.
22. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009;24:1803-10.
23. Lee JY, Jeon BS, Kim HJ, Park SS. Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. Parkinsonism Relat Disord 2011 Sep 5 [Epub ahead of print]. doi: 10.1016/j.parkreldis.2011.08.009.
24. Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008;23:75-80.
25. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010;67:58-63.
26. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 2010;68:400-4.
27. Bermejo PE, Ruiz-Huete C, Anciones B. Zonisamide in managing impulse control disorders in Parkinson's disease. J Neurol 2010;257:1682-5.
28. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006;21:1941-6.
29. Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009;16: 1148-52.